B

Bolt Biotherapeutics
D

BOLT

0.61300
USD
0.01
(1.68%)
Market Closed
Volume
299
EPS
-2
Div Yield
-
P/E
-0
Market Cap
23,461,350
OverviewSignalsIdeasNews
Related Instruments
    E
    ENJ
    -0.010
    (-0.04%)
    23.140 USD
    S
    SAND
    -0.13500
    (-2.46%)
    5.36000 USD
    More
News

Title: Bolt Biotherapeutics

Sector: Healthcare
Industry: Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.